To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Acute myelogenous leukemia (AML)
In vitro and mouse studies identified a pyrazolone-based BAX activator that
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury